Startup Funding

Menu
Subscribe
Search
Why Early AI Revenue Hides More Risk Than It Removes

Why Early AI Revenue Hides More Risk Than It Removes

•
Fundraising, Investing

Related Guides

    Trending

    The most popular articles on Startup Funding in the past day.

    Why Early AI Revenue Hides More Risk Than It Removes

    April 12, 2026

    5 min read Why Early AI Revenue Hides More Risk Than It Removes In today’s AI market, early revenue is often treated as proof of momentum. A signed contract, a recognizable customer logo, or a growing usage chart can quickly create the impression that risk is coming off the table. For many investors, that feels like validation. But in AI, early revenue often does not reduce risk. It often conceals it. At TEN Capital, we believe this distinction matters most for family offices and long-term investors. In emerging categories, revenue can create a sense of comfort before a business has earned durability. And when that happens, investors are not underwriting certainty. They are underwriting a story. The real question is not whether an AI company has revenue. The real question is whether that revenue reveals a durable business model. or delays the discovery of its weaknesses. Revenue Is Not the Same as Validation In traditional software, early revenue has often been a meaningful signal. It can suggest product-market fit, pricing power, and disciplined execution. Investors have been trained to see revenue as evidence that a company is moving in the right direction. AI requires a more careful lens. Many early AI buyers are not making long-term purchasing decisions. They are testing capabilities, funding internal learning, and exploring what the technology can do. In other words, they are often buying experimentation rather than embedding a permanent solution into the business. That is why early AI revenue can be misleading. It may look like commercial traction, while in reality, it reflects temporary curiosity, discretionary budget allocation, or non-repeatable deployments. For investors, especially those focused on downside protection, this is where diligence has to deepen rather than relax. The Pilot Trap That Inflates Confidence One of the most common distortions in AI investing is the way early revenue is categorized and interpreted. What looks like recurring revenue is often one of three things: pilot revenue dressed up as ARR, consulting work reported as product revenue, or subsidized experimentation that has not yet faced real commercial pressure. These revenue streams can look strong in a deck or spreadsheet, but they tend to behave poorly under stress. They churn faster, stall during procurement, get repriced under scrutiny, or disappear entirely when budgets tighten. The danger is not simply that these revenues are fragile. The deeper problem is that founders and investors often value them as if they are durable. Once that happens, the business gets framed as de-risked before the hard questions have been answered. The Cost Curve Is Where the Risk Actually Lives For AI companies, revenue alone tells only a small part of the story. The more important issue is whether the economics improve or deteriorate as usage grows. Early AI revenue often arrives before true unit economics are visible. Compute costs may still be partially subsidized. Engineering labor may be buried inside implementation. Inference expenses may rise faster than pricing can support. Gross margin assumptions may look promising in theory while remaining unproven in practice. This is why early traction can be deceptive. Revenue growth can delay the moment when investors are forced to confront whether the business actually scales in an economically sound way. A company can appear to be gaining momentum even as its underlying cost structure grows more fragile with each additional customer. Why Early Revenue Can Weaken Diligence In many cases, revenue does not sharpen investor discipline. It softens it. Without revenue, investors tend to ask harder questions immediately. What happens when usage expands? What happens when the underlying models commoditize? What happens when pricing compresses? What happens if the customer internalizes the capability instead of continuing to pay for it? Once revenue exists, those questions often lose urgency. The company starts to look validated. The conversation shifts from structural risk to growth narrative. And that is often the point where the most important diligence gets deferred. In AI, revenue should not be treated as an excuse to stop probing. It should be treated as a prompt to understand exactly what is being monetized, and how durable that monetization really is. Why Family Offices Need a Different Lens This matters to all investors, but especially to family offices. Traditional venture funds can tolerate weaker businesses because portfolio construction allows a few exceptional winners to drive returns. High churn, unclear retention, and low margins can be survivable at the fund level if one outlier eventually breaks through. Family offices usually play a different game. They are often more focused on capital preservation, risk-adjusted outcomes, and long-term compounding. They feel opportunity cost more directly. They absorb underperformance differently. And they generally have less tolerance for narratives that take years to resolve into economic truth. That makes fragile AI revenue particularly dangerous. When early revenue delays the discovery of weakness, family offices are often the first to feel the cost of that mistake. What Actually De-Risks an AI Business At TEN Capital, we believe the strongest de-risking signals in AI are structural, not cosmetic. Headline ARR matters far less than the durability beneath it. Investors should spend more time on questions like: Can margins remain resilient as the company scales?How deeply does the customer depend on the product?Are switching costs real or merely assumed?Is the cost structure transparent?Can the founder clearly explain downside scenarios and uncomfortable numbers? These are the markers of a company that understands its own business model. Revenue without this level of clarity is often just decoration. Revenue with this level of clarity is much closer to evidence. A Better Question Than “How Much ARR?” There is a more useful question investors should be asking: What happens to this revenue when pricing power weakens? That question cuts through hype quickly. It forces a conversation about margin sensitivity, customer behavior, the risk of commoditization, and retention durability. It reveals whether the company has built real leverage — or is simply benefiting from temporary market enthusiasm. In our view, that single question filters out a meaningful share of fragile

    The Timing Advantage: Why This Decade Will Define Startup Investing

    March 29, 2026

    5 min read The Timing Advantage: Why This Decade Will Define Startup Investing Every investor says they care about market timing. They talk about cycles.They talk about entry points.They talk about discipline. But here is the uncomfortable truth: Most investors still deploy capital at the peak of confidence, not at the point of opportunity. The investor says, “I’ll invest when the market stabilizes.”The market responds, “The best returns were already taken.” This isn’t a data problem.It’s a psychological problem. Investors think they are managing risk.In reality, they are avoiding discomfort, waiting until things feel safe. And safety is expensive. The difference between average returns and top-decile outcomes isn’t access.It’s timing. The Wrong Goal: Waiting for Certainty Most investors believe the goal is to wait: For stabilityFor clarityFor better signalsFor momentum It feels logical, but it’s flawed. By the time things feel “safe”: Valuations have already increased Competition has already returned The best deals are already gone Waiting doesn’t reduce risk.It reduces upside. The Real Question Investors Should Be Asking Most investors ask:“Is this the right time to invest?” Better question:“Where are we in the cycle, and who wins here?” Even better:“Am I early enough to capture asymmetric returns?” Market timing isn’t about predicting the future.It’s about recognizing the present. This Isn’t a Downturn—It’s a Reset The post-pandemic market created: Too much capital Inflated valuations Unsustainable growth expectations The correction that followed didn’t break the system; it fixed it. It removed weaker companies.It forced discipline.It reset pricing. This isn’t a decline.It’s a recalibration. And historically, this is where the best investments are made. Why This Moment Is Different The headlines say the market is harder. The reality? It’s better for the right investors. Right now, you have: Lower entry valuations Stronger, more disciplined founders Less competition for deals More efficient companies At the same time: AI is moving into real-world adoption Biotech and healthcare innovation are accelerating Enterprise demand is quietly returning This combination is rare. It’s what creates outsized returns. Framework: How to Read Market Timing To understand if it’s the right moment, look at five signals: 1. Valuations are downLower prices = higher potential upside 2. Capital is tighterLess funding = less competition 3. Founders are strongerOnly serious builders stay in tough markets 4. Technology is maturingReal products, not just hype 5. Demand is building againGrowth returns fast once confidence does When all five are present, you’re not late. You’re early. How to Invest in This Cycle A simple approach: Step 1 — Accept the resetThe market has already corrected. Step 2 — Focus on inevitable sectorsAI, healthcare, climate, automation Step 3 — Back non-replaceable companiesNot just “better”—but hard to replicate and positioned to win Step 4 — Move before consensusIf it feels obvious, it’s already priced in. Three Rules to Remember 1. If it feels safe, it’s too lateSafety means the upside is already shrinking 2. Consensus is a lagging signalBy the time everyone agrees, returns are lower 3. Timing multiplies everythingGreat company + wrong timing = average returnGood company + right timing = great return What the Best Investors Do Differently They don’t wait. They: Invest during uncertainty Lean into overlooked opportunities Focus on long-term trends Build positions early Ignore short-term noise They understand one thing: The best opportunities never feel obvious in real time. The Closing Thought This decade will define the next generation of startup winners. Not just because of what gets built—But because of when capital gets deployed. Most investors will wait for clarity. A few will recognize that this moment, right now, is where the real opportunity is. The question isn’t: “Is this the right time to invest?” It’s: “Will you act before everyone else does?”

    How to Diligence the Team Behind the Tech

    February 22, 2026

    5 min read  How to Diligence the Team Behind the Tech Assessing leadership readiness, decision velocity, and team adaptability as predictors of scaling success. Technology attracts attention. Code demos impress. Product roadmaps inspire. But companies don’t scale solely because of technology. They scale because of the people making decisions behind it. Professional investors understand this: great technology in the hands of an unprepared team rarely survives growth. Meanwhile, capable leadership can iterate, pivot, and rebuild even when the first product misses. When evaluating early-stage opportunities, diligence is not a soft exercise. It’s a predictive one. Below is a practical framework for assessing leadership readiness, decision velocity, and adaptability, the core traits that determine whether a team can scale what they’ve built. Leadership Readiness → “Are They Built for the Next Stage?” Founders often succeed at starting companies. Scaling them requires a different skill set. Early-stage leadership is about creativity and hustle. Scaling-stage leadership is about structure, delegation, and capital allocation. The key question: Is this team prepared for the company they’re trying to become? Pressure-test: Have they hired executives before, or only individual contributors? Do they understand financial drivers beyond product development? Can they articulate a 12–24-month hiring roadmap tied to milestones? Have they operated through a prior growth phase, or only early formation? Strong readiness signals look like: Clear recognition of their own capability gaps Defined role ownership across leadership Thoughtful sequencing of hires Comfort with accountability and reporting structures Red flag: “We’ll figure out management when we get there.” Scaling punishes improvisation. Leadership maturity reduces operational drag before it compounds. Decision Velocity → “How Fast and How Well Do They Decide?” In scaling companies, speed is a strategic weapon. But speed without judgment is volatility. Decision velocity isn’t just about moving quickly. It’s about moving decisively with incomplete information—and learning from outcomes. Evaluate: How long does it take them to prioritize? Do decisions require consensus—or is authority clear? Can they explain past pivots in terms of logic, not emotion? Do they track the outcomes of major decisions? Strong velocity signals look like: Documented decision frameworks Defined escalation paths Willingness to kill underperforming initiatives Evidence of rapid iteration cycles Red flag: Endless debate disguised as collaboration. Markets move. Competitors adapt. Capital runs out. Teams that cannot decide under uncertainty create internal bottlenecks that stall growth. Scaling companies don’t fail from a lack of ideas. They fail from decision paralysis. Team Adaptability → “Can They Evolve Without Breaking?” Every growth stage introduces friction: New customer segments New compliance requirements New pricing pressures New competitors The team that built version 1.0 may not automatically be the one to build version 3.0. Adaptability is the ability to: Reallocate resources quickly Replace underperforming leaders Adopt new systems Accept external expertise Pressure-test: Have they pivoted before? Did they blame the market, or analyze their own assumptions? Are they coachable? How do they respond to critical board feedback? Strong adaptability signals look like: Transparent post-mortems Iterative roadmap updates Openness to external advisors Recruiting talent stronger than the founders Red flag: Attachment to original vision at the expense of evidence. Technology evolves. Markets shift. Investors change expectations. Teams that treat adaptation as weakness often collapse under scale pressure. Talent Density → “Who Do They Attract?” Strong leaders attract strong operators. Examine: Early key hires, are they high leverage? Retention of top contributors Clarity in organizational design Cultural alignment with performance expectations High-talent teams show: Intentional hiring, not opportunistic Clear performance metrics Fast removal of misaligned hires Leadership depth beyond the founder Red flag: Overreliance on one visionary individual. Scaling requires distributed competence. When decision-making, product insight, and customer relationships concentrate in one person, fragility increases. Alignment Under Stress → “What Happens When Things Go Wrong?” Every scaling journey encounters setbacks: Missed revenue targets Delayed product releases Capital shortfalls The real diligence happens in how teams describe difficult moments. Listen for: Ownership vs. deflection Structured problem-solving vs. emotional reaction Cohesion vs. internal blame Strong stress signals look like: Shared accountability language Clear corrective action plans Data-driven explanations Confidence without denial Red flag: Narrative revisionism. Teams that rewrite history rather than analyze it repeat mistakes at scale. How These Factors Interact Leadership readiness without decision velocity creates bureaucracy. Decision speed without adaptability creates reckless pivots. Adaptability without alignment creates internal churn. Investors aren’t looking for perfection. They’re looking for: Clear growth awareness Defined authority structures Evidence of learning Capacity to recruit beyond themselves Resilience under pressure Technology scales when leadership scales with it. Why Team Diligence Outperforms Product Diligence Products change. Markets evolve. Models iterate. But leadership patterns tend to persist. A disciplined team: Improves weak products Adjusts pricing Finds distribution Raises follow-on capital An undisciplined team: Burns capital faster Creates internal confusion Resists oversight Blames external factors When technology fails, strong teams rebuild. When teams fail, technology rarely saves them. Final Thoughts Diligencing the team behind the tech is not about personality fit or charisma. It’s about operational indicators of scaling readiness. Ask: Are they built for the next stage? Can they decide under uncertainty? Will they adapt when conditions shift? Do they attract and retain talent? Do they hold alignment under stress? The strongest predictors of scaling success are rarely in the demo. They are in the decision patterns, hiring discipline, and leadership maturity of the people running it. Technology may open the door. Leadership determines whether the company walks through it. Want structured team-diligence scorecards, leadership assessment templates, and scaling-readiness evaluation tools used by experienced investors? Join our investor community for practical frameworks designed to help you underwrite teams, not just technology, and invest with greater clarity and conviction.

    Screening for the Win: How Great Investors Separate Noise from Signal

    February 15, 2026

    5 min read  Screening for the Win: How Great Investors Separate Noise from Signal Applying structured screening to early-stage deals—where hype is loud, data is thin, and discipline makes the difference. Every cycle produces noise. New sectors trend on social media. Valuations spike. Founders master pitch theater. Markets reward momentum—until they don’t. Professional investors don’t win by chasing excitement. They win by filtering it. The difference between average and exceptional investors isn’t access to deals. It’s a structured screening. Before deep diligence begins, great investors run opportunities through five disciplined filters: Market Timing Defensibility Economics Execution Governance These filters don’t predict outcomes. They clarify risk. They separate the signal from the narrative. Below is a practical screening framework used by experienced investors to quickly assess whether a deal deserves conviction—or polite decline. 1. Filter One: Market Timing → “Why Now?” Timing is the silent multiplier in venture outcomes. A great company in a premature market struggles. A solid company in a catalytic moment accelerates. The key question isn’t whether the market is large. It’s whether the inflection has arrived. Pressure-test: Has a structural shift occurred? (regulation, cost curve, behavior change, infrastructure maturity) Is adoption accelerating independently of this company? Are incumbents adapting—or still dismissing the category? Would this have failed five years ago? What changed? Strong timing signals look like: Cost reductions unlocking new use cases Policy or compliance forcing adoption Platform shifts creating new distribution rails Budget reallocation is already happening Red flag: “The market is huge” without evidence that buyers are ready. Markets don’t reward potential energy. They reward activation. 2. Filter Two: Defensibility → “If This Works, Can It Last?” Speed builds companies. Moats protect them. Early growth without defensibility invites competition. Professional investors ask whether success compounds—or attracts erosion. Assess structural advantage: Proprietary data or network effects Switching costs or workflow integration Regulatory approvals or compliance barriers Brand trust in risk-sensitive markets Cost advantages that scale Strong defensibility signals look like: Advantage strengthens with scale Competitors face rising marginal difficulty Customers embed the product deeply into their operations Red flag: Defensibility based purely on “first mover.” In modern markets, first rarely wins. Structural advantage does. 3. Filter Three: Economics → “Does the Model Actually Work?” Revenue growth can hide fragile economics. Professional investors look beyond topline momentum to economic logic. Pressure-test: Unit economics at scale—not just today Contribution margins after realistic cost assumptions Customer acquisition efficiency Payback timelines Capital intensity requirements The goal is not perfection. Its viability. Strong economic signals look like: Improving margins with scale Clear path to positive contribution margin Revenue quality (recurring, sticky, diversified) Sensible capital requirements relative to outcomes Red flag: “We’ll figure out monetization later.” Even disruptive models require economic coherence. Growth amplifies what’s underneath. If the foundation is weak, scale accelerates failure. 4. Filter Four: Execution → “Can This Team Actually Deliver?” Ideas are common. Execution is rare. Investors aren’t funding slides. They’re underwriting judgment under pressure. Evaluate: Founder decision-making history Speed of iteration Talent density Role clarity across leadership Evidence of learning from mistakes Strong execution signals look like: Clear prioritization under constraint Willingness to pivot based on evidence Transparent articulation of risks Thoughtful hiring strategy Red flag: Vision without operational depth. Great teams convert ambiguity into progress. Weak teams amplify chaos. 5. Filter Five: Governance → “Will This Scale Without Breaking?” Governance rarely excites investors—but it frequently determines outcomes. As companies grow, misaligned incentives and unclear authority create hidden risk. Pressure-test: Board composition and independence The founder’s openness to accountability Transparency in reporting Clean cap table structure Alignment between short-term decisions and long-term value Strong governance signals look like: Structured decision processes Clear communication cadence Professional financial discipline Long-term alignment among stakeholders Red flag: Founder defensiveness toward oversight. Capital scales opportunity—but it also scales dysfunction. How the Five Filters Work Together These filters are not independent. Strong market timing without defensibility creates churn. Strong economics without governance creates instability. Strong execution without timing creates frustration. Professional investors don’t look for perfection. They look for: One or two undeniable strengths No fatal weaknesses Clear understanding of risks Evidence that progress reduces uncertainty The goal of screening isn’t to eliminate risk. It’s to ensure risk is intentional. Why Structured Screening Beats Instinct Instinct matters. But instinct without structure drifts toward bias. Without filters: Charismatic founders overpower analysis Trend narratives override discipline FOMO replaces underwriting Decision thresholds move mid-process Structured screening prevents: Endless “maybe” deals Time sink diligence Emotional investing Inconsistent standards The best investors define their filters before the pitch—not after it. Final Thoughts Separating noise from signal is a discipline. Great investors don’t chase what’s loud. They: Anchor decisions in structural timing Demand durable advantage Underwrite economic logic Assess execution realism Insist on scalable governance They don’t eliminate uncertainty. They filter it. Over time, consistent filtering compounds. Conviction improves. Losses shrink. Capital allocates with purpose. Signal becomes clearer—not because the market changes, but because the lens does. Want access to structured screening templates, deal scoring frameworks, and investor decision matrices built around these five filters? Join our investor community for practical tools designed to help you separate noise from signal—screen smarter, underwrite better, and invest with discipline.

    From Pitch to Proof: Turning Diligence into Decision

    January 25, 2026

    5 min read From Pitch to Proof: Turning Diligence into Decision How to structure diligence milestones that convert investor curiosity into conviction—and founders’ claims into evidence. Early-stage investing rarely fails because of a lack of interesting pitches. It fails because diligence drags, questions sprawl, and momentum dies in the face of ambiguity. Investors get curious, founders get hopeful—and then nothing happens. Great diligence isn’t about exhaustive analysis. It’s about structured progression. The best investors use clear diligence milestones to turn a compelling story into verifiable proof, and to move efficiently from “this is interesting” to “this is investable.” Diligence, done right, is both an art and a science. The science is in sequencing evidence, defining decision gates, and aligning on what “enough proof” actually means. The art is knowing which questions matter now, and which can wait. Below is a practical framework for designing diligence milestones that accelerate decisions, reduce friction, and increase conviction on both sides of the table. 1. Diligence as a Funnel, Not a Checklist The biggest mistake in diligence is treating it like a flat list of questions. Effective diligence is progressive; each stage earns the right to go deeper. Ask one guiding question at every phase: What must be true to move forward? Structure diligence into clear stages: Narrative validation Evidence confirmation Risk underwriting Decision readiness Each stage should narrow uncertainty—not expand it. 2. Milestone 1: Narrative Coherence → “Does the Story Hold?” This stage tests whether the pitch withstands scrutiny before data deep dives begin. Objective: Validate internal consistency, clarity, and logic. What to pressure-test: Problem definition vs. customer urgency Why this solution wins now Founder’s understanding of tradeoffs and constraints Alignment between vision, strategy, and near-term execution Proof looks like: Clear, repeatable articulation (not rehearsed buzzwords) Ability to explain the why, not just the what Consistent answers across conversations Red flag: The story evolves defensively instead of sharpening. Only narratives that hold together deserve deeper diligence. 3. Milestone 2: Evidence of Traction → “Is There Behavioral Proof?” This is where claims meet reality. Objective: Replace founder assertions with observable behavior. Validate through: Customer calls (listen for unprompted enthusiasm or frustration) Usage, retention, or engagement patterns Sales process reality vs. Slideware Why customers buy, don’t buy, or churn Proof looks like: Customers describing value in their own word Patterns across similar buyers Clear articulation of ICP and non-ICP Green flag: Founders openly discuss lost deals and weak signals. Traction diligence isn’t about scale—it’s about signal quality. 4. Milestone 3: Execution & Team Risk → “Can This Team Deliver?” Ideas don’t fail—execution does. Objective: Assess whether the team can translate momentum into outcomes. Focus on: Decision-making cadence Role clarity and ownership Ability to prioritize under constraints Learning velocity from mistakes Proof looks like: Evidence of shipping, iterating, and cutting scope Clear accountability (not consensus paralysis) Founders’ awareness of their own blind spots Red flag: Blaming externalities for execution gaps. Strong teams turn ambiguity into progress. 5. Milestone 4: Capital & Downside Underwriting → “Does the Risk Make Sense?” Only now does deep financial and structural diligence matter. Objective: Ensure capital is being used to reduce risk—not defer it. Underwrite: Burn relative to milestones achieved Use of funds tied to specific de-risking events Cap table cleanliness and incentive alignment Runway realism vs. fundraising optimism Proof looks like: Thoughtful capital planning Milestone-driven fundraising logic Governance readiness earlier than “necessary”. Early financial discipline predicts late-stage survivability. 6. Decision Gates: Define “Enough” in Advance The fastest investors don’t rush; they predefine conviction thresholds. Before diligence begins, clarify: What would cause a hard stop? What evidence is sufficient for a yes? What risks are acceptable at this stage? This prevents: Endless follow-up questions Moving goalposts Founder fatigue Diligence should feel directional, not infinite. 7. Founder Experience Matters (More Than You Think) How you run diligence is a signal. Founders infer: How you’ll behave in boardrooms How you’ll handle future tension Whether you decide—or drift Clear milestones create trust, even in the past. Best practice: Tell founders where they are in the process and what comes next. Final Thoughts Diligence is not about proving a company is perfect. It’s about proving that the risks are known, intentional, and worth taking. When structured well: Investor curiosity becomes conviction Founder narratives become evidence Decisions happen faster—with more confidence The best investors don’t just ask better questions. They design better paths to answers. Want to turn diligence into a competitive advantage? Join our investor community to access proven diligence milestone frameworks, evidence maps, and decision-gate templates—designed to help you move from pitch to proof faster, and say “yes” with clarity when it counts.

    The 3×3 Framework for Predictable Startup Investing

    January 19, 2026

    5 min read The 3×3 Framework for Predictable Startup Investing Early-stage investing is not about eliminating uncertainty; it’s about controlling duration, defining liquidity, and aligning incentives before risk compounds. While traditional venture models rely on long holding periods and binary outcomes, most returns or losses are determined far earlier than the exit slide suggests. The 3×3 Early Exit Framework was designed to address this structural mismatch. Instead of underwriting distant, hypothetical outcomes, it introduces clear time horizons, multiple liquidity paths, and systematic evaluation criteria that make early-stage investing more predictable and repeatable. Whether you’re an angel investor, family office, or disciplined venture fund, the 3×3 Framework offers a practical alternative to story-driven investing—one grounded in execution, capital efficiency, and realistic exit logic. Below is a structured, investor-ready breakdown of the 3×3 Early Exit model’s 3 pillars and 3 outcomes. 1. Time Discipline: Three Years, Not a Decade   a. Defined Investment Horizon Traditional venture investing assumes holding periods of 8–12 years. The 3×3 Framework instead evaluates whether a company can reach meaningful de-risking or liquidity within 36 months. Assess: Can the business reach revenue, profitability, or strategic relevance in three years? Are milestones tied to execution, not future fundraising? Is the company survivable without perfect market conditions? Shorter horizons reduce duration risk and force operational clarity. b. Milestone-Based Capital Deployment Capital is deployed with intent—not hope. Evaluate: What risks does each dollar retire? Are milestones technical, commercial, or regulatory—and measurable? Does progress increase exit optionality? Companies that can’t articulate near-term value creation are poor candidates for early liquidity. c. Optionality Over Dependency The model avoids companies that require multiple follow-on rounds to remain viable. Look for: Revenue paths independent of venture markets Controlled burn relative to progress Strategic relevance without scale-at-all-costs pressure Time discipline creates leverage—for both founders and investors. 2. Liquidity First: Three Realistic Exit Paths   a. Strategic Acquisition Readiness Instead of betting on unicorn outcomes, the 3×3 model underwrites who could buy this company—and why—within 24–36 months. Assess: Clear buyer profiles Metrics that matter to acquirers Strategic positioning inside industry workflows Exit readiness is not an afterthought—it’s a design constraint. b. Structured or Partial Liquidity Liquidity doesn’t have to mean a full sale. Evaluate: Secondary transactions Redemption or revenue-based structures Early return mechanisms tied to cash flow Partial liquidity improves capital recycling and reduces binary risk. c. Downside-Resilient Outcomes The framework assumes not every company exits perfectly. Look for: Capital preservation scenarios Businesses that can sustain modest outcomes Paths to return capital even without breakout success Defined liquidity beats theoretical upside. 3. Incentive Alignment: Execution Over Hype   a. Founder Incentives Aligned to Outcomes The 3×3 model favors founders who value: Capital efficiency Revenue clarity Sustainable growth Optionality over valuation chasing Founders are rewarded for building real businesses, not just raising rounds. b. Investor Discipline Over Narrative The framework replaces gut feel with structure. Assess companies based on: Execution readiness Capital-to-milestone efficiency Buyer relevance Operational maturity This enables consistent screening and comparability across deals. c. Systematic Evaluation The 3×3 Framework integrates cleanly with: First-pass filters Scoring matrices Diligence checklists Early Exit fit assessments Predictability improves when process replaces improvisation. Early-stage outcomes are never guaranteed—but they are rarely random. The same forces repeatedly determine success: time, liquidity, and alignment. The 3×3 Early Exit Framework brings those forces forward, making them explicit rather than implied. Great investors don’t rely on best-case scenarios.They design portfolios that perform across many futures. The 3×3 model doesn’t eliminate risk—it makes risk visible, measurable, and manageable.

    How to Diligence a Deal Beyond the Deck

    December 14, 2025

    10 min read How to Diligence a Deal Beyond the Deck A practical framework for investors to go deeper than the pitch—focusing on risk domains, capital discipline, and founder transparency. Pitch decks are designed to persuade, not to fully inform. They highlight upside, compress complexity, and often gloss over risk. For investors, relying on the deck alone is one of the fastest ways to misprice risk and overestimate execution. Whether you’re an angel investor, family office, strategic, or venture fund, diligence on a deal beyond the deck requires a structured, skeptical, and evidence-driven approach. The goal isn’t to kill deals to build conviction by understanding where things can break and whether the team has the discipline to navigate those risks. Below is a practical framework to go deeper than the pitch and evaluate a company across its true risk domains. 1. Business Model Clarity & Unit Economics   a. How the Company Actually Makes Money Start by stress-testing the revenue model—not the TAM slide. Ask: Is revenue transactional, recurring, usage-based, or contract-driven? Who is the buyer vs. the end user? What triggers revenue recognition? Break down cost drivers: COGS or service delivery costs Sales commissions and customer success Infrastructure, tooling, or third-party dependencies Look for: Clear margin expansion logic Evidence that costs decline with scale, not just assumptions If unit economics don’t work at a small scale, they rarely work later. b. LTV, CAC, and Payback Reality Founders often present optimistic LTV/CAC ratios. Your job is to pressure-test them. Validate: CAC by channel (not blended averages) Sales cycle length by customer segment Retention, expansion, and churn assumptions Ask: How long does it take to recover CAC on a cash basis? What happens to CAC as the company scales? Are early customers representative—or exceptions? c. Pricing Power & Market Sensitivity Understand whether pricing is: Cost-plus Value-based Competitive or commoditized Test: What happens if prices drop 20%? Can customers easily switch? Is pricing driven by ROI, urgency, or convenience? Real businesses survive pricing pressure. Fragile ones don’t. 2. Risk Domains: Where the Business Can Break Great diligence maps risk before upside. Key risk domains to assess: Market risk (is the problem real and urgent?) Product risk (does it work as claimed?) Execution risk (can the team deliver?) Financial risk (capital sufficiency and burn discipline) Regulatory or compliance risk (if applicable) Dependency risk (customers, vendors, platforms) Ask founders directly: “What are the top three things that could kill this company?” How they answer matters as much as what they say. 3. Product Reality vs. Product Narrative   a. Product-Market Fit Evidence Look for proof—not promises. Validate through: Customer usage data Retention and engagement metrics Pilot-to-paid conversion rates Reference calls with real users Red flags: Heavy roadmap focus with light customer evidence Features driving excitement but not retention “Design partners” that never convert b. Roadmap Discipline A strong roadmap is prioritized, resourced, and sequenced. Ask: What gets built next—and why? What’s customer-driven vs. founder-driven? What milestones unlock revenue or margin? Avoid teams chasing breadth before depth. 4. Go-to-Market Execution   a. Sales Motion Fit Evaluate whether the GTM motion aligns with the product and the buyer. Assess: Self-serve vs. sales-led vs. enterprise Founder-led sales dependency Channel vs. direct strategy Red flags: Long enterprise cycles without a capital runway Complex sales motions with junior teams No clear ICP definition b. Pipeline Quality Inspect pipeline health—not just top-line numbers. Look for: Stage conversion rates Deal slippage patterns Customer concentration risk One “logo” does not equal traction. 5. Founder Transparency & Integrity This is where diligence moves from analytical to judgment-based. Strong founders: Share bad news early Acknowledge weaknesses Provide clean, consistent data Don’t over-defend assumptions Watch for: Shifting answers across meetings Overly polished responses to hard questions Resistance to data requests Trust is built through consistency under pressure. 6. Team & Execution Capacity   a. Role Coverage Evaluate whether critical functions are owned: Product Sales Operations Finance Early-stage teams don’t need depth everywhere—but they need awareness of gaps. b. Execution Track Record Ask: What milestones were hit late—and why? Where has the team over- or under-estimated? How do they course-correct? Past execution is the best predictor of future execution. 7. Financial Discipline & Capital Strategy   a. Burn vs. Learning Healthy burn drives learning and de-risking—not just growth optics. Assess: Monthly burn vs. milestone progress Headcount growth vs. productivity Spend aligned to key risks   b. Capital Plan Reality Understand: How long does the current capital last What milestones justify the next raise Downside survival scenarios Ask: “If fundraising takes 6 months longer than expected, what happens?” 8. Cap Table & Incentive Alignment Review: Ownership distribution SAFEs, notes, and preference stacks Employee option pool health Red flags: Overcrowded early cap tables Misaligned investor rights Founder dilution that kills motivation 9. Market Context & Competitive Positioning Map: Direct competitors Indirect substitutes Incumbent responses Assess: Switching costs Differentiation durability Speed of competitive response Winning often depends on timing, not just product quality. 10. Exit Logic & Investor Fit   a. Plausible Exit Paths Ask: Who buys companies like this? At what scale? On what metrics? Hope is not a strategy, exits follow patterns. b. Alignment Check Finally, assess: Time horizon fit Risk tolerance alignment Strategic vs. financial expectations A good deal for someone else can be a bad deal for you. Final Thoughts Diligencing a deal beyond the deck is about discipline, curiosity, and humility. It means resisting the story long enough to examine the structure underneath—and deciding whether the risks are known, manageable, and worth taking. By applying a structured framework, grounded in unit economics, risk domains, founder transparency, and capital discipline, you move from guessing to conviction. The best investors don’t avoid risk. They understand it better than anyone else in the room.   Hall T. Martin is the founder and CEO of the TEN Capital Network. TEN Capital has been connecting startups with investors for over ten years. You can connect with Hall about fundraising, business growth, and emerging technologies via LinkedIn or email: hallmartin@tencapital.group

    How to Diligence a Medical Device Startup

    November 30, 2025

    min read How to Diligence a Medical Device Startup How to Diligence a Medical Device Startup A comprehensive investor guide to evaluating clinical value, regulatory risk, and commercialization potential Medical device startups operate within one of the most complex innovation categories, requiring mastery across engineering, clinical medicine, regulation, manufacturing, and reimbursement. For investors, diligence on these companies requires a structured, evidence-based approach that goes far beyond the pitch deck. This guide outlines how to properly diligence a medical device startup, integrating core industry frameworks, regulatory expectations, and the milestone roadmap unique to medtech innovation. Key content to highlight essential metrics, timelines, and development paths. 1. Clinical Problem & Unmet Need Every strong medical device startup begins with a validated, painful clinical problem. The most investable solutions are those that clearly improve outcomes, reduce complications, save clinician time, or reduce healthcare costs. Diligence Questions Is the problem clinically significant and supported by evidence Is the startup solving a proven, unmet need, or is it simply a “nice-to-have”? Does the device fit naturally into a clinician’s workflow? Evidence to Request Peer-reviewed publications Interviews with clinicians (surgeons, nurses, technicians) Hospital pilot interest or letters of support Workflow analysis Clinical validation is not optional; investors should look for early signs that the device will be accepted in practice. 2. Technology, Engineering Maturity & IP Investors must evaluate whether the technology is real, reliable, and defensible. Key Areas to Diligence Prototype functionality (bench testing, usability testing) Software validation (IEC 62304) Human factors engineering (IEC 62366) Reliability and failure mode testing Freedom-to-operate and patent filings Prototypes vs. Clinical Units Prototypes → used for engineering tests and early feedback Clinical unit → the version intended for formal clinical testing Investors should verify that the startup understands and is progressing toward an actual clinical unit, not just a lab prototype. 3. Regulatory Pathway, Risk Class, & Key Metric The regulatory pathway defines cost, timeline, risk, and capital needs. Misjudging it is one of the most common investor mistakes. Your One Key Metric: 510(k) Cycle Time For medical device startups, the key performance metric is not revenue, but rather: Cycle Time Through the 510(k) Application and Approval Process Why? A medical device cannot generate revenue until it receives FDA clearance. The 510(k) process exists to demonstrate that the device is at least as safe and effective as a predicate device already on the market. The typical cycle time ranges from: 50–300 days, depending on device complexity. Investors should ask the startup: What is the standard cycle time for comparable devices? How are you benchmarking against that? What regulatory consultant or QA/RA firm is guiding your path? Understanding this timeline is essential to evaluating execution risk and funding needs. 4. Clinical Evidence, Validation & Trials Investors must examine whether the startup is producing the right evidence at the right time. Core Stages of Clinical Validation Preclinical validation – Initial safety and bench/animal tests First-in-human tests – Early clinical study Clinical validation – Broader human clinical trial data Evidence to Request Cadaver/animal study results Human factors reports Early feasibility human data Biocompatibility and electrical safety testing Strong startups demonstrate a clear, statistically powered plan for pivotal clinical trials, including sites, budget, endpoints, and timeline. 5. Manufacturing, Quality Systems & Supply Chain A medtech startup must eventually scale hardware manufacturing, a central diligence area many investors overlook. Diligence Checklist Design for manufacturability (DFM) Supplier qualification Sterilization pathway and validation Packaging and shelf-life testing ISO 13485-aligned quality management system Without proper QMS and design controls, FDA clearance and manufacturing scale become extremely risky. 6. Reimbursement Strategy & Commercial Model Even with FDA approval, a device can fail commercially without reimbursement. Key Reimbursement Questions Is there an existing CPT, HCPCS, or DRG code? Will a new code be required? What is the economic value to hospitals and providers? Are early health economic studies underway? Strong startups can demonstrate real cost savings or efficiency improvements that justify purchasing. 7. Team, Advisors, & Capital Strategy Execution in medtech requires multidisciplinary excellence. What to Look For Founders with clinical or engineering depth Regulatory and quality expertise Key opinion leaders (KOLs) involved early Experience with device commercialization Capital Planning Medical device development often requires three to five years to reach FDA clearance and initial sales. Investors should verify: Milestone-based fundraising strategy Clear runway aligned to regulatory events. Transparent burn projection 8. The Medical Device Roadmap: A Critical Diligence Tool Medical Device Startup Roadmap Market requirements Product requirements Prototypes Clinical unit Preclinical validation First-in-human test Clinical validation CE Mark (Europe) First European orders 510(k) clearance (US) First US orders Break-even Growth and scale Why this matters for diligence Investors should map the startup’s current stage against this roadmap to evaluate: How far they’ve progressed Whether they are ahead or behind industry norms Whether capital needs align with upcoming milestones What risks remain before revenue is possible This roadmap provides a clear, standardized structure for evaluating readiness and execution risk. Common Red Flags During Diligence No predicate identified for 510(k) No regulatory consultant engaged Confusion between intended use and indications for use Only early prototypes, no pathway to a clinical unit Unrealistic regulatory timelines Limited or no clinical advisor involvement Weak or nonexistent reimbursement plan Underestimation of hospital sales cycles (12–24 months) Diligencing a medical device startup requires a holistic approach that integrates: Clinical need Technology maturity Regulatory strategy 510(k) cycle-time metrics Clinical validation Manufacturing readiness Reimbursement viabilit Team capability Roadmap alignment Capital planning By using these frameworks, especially the medical device roadmap and the 510(k) cycle time regulatory metric, investors can distinguish between a promising concept and a fundable medtech venture capable of achieving clinical and commercial success. Read More from TEN Capital Education here. Hall T. Martin is the founder and CEO of the TEN Capital Network. TEN Capital has been connecting startups with investors for over ten years. You can connect with Hall about fundraising, business growth, and emerging technologies via LinkedIn or email: hallmartin@tencapital.group

    How to Diligence a Marketplace Startup

    November 9, 2025

    10 min read How to Diligence a Marketplace Startup The Hidden Complexity of Marketplace Investing Marketplace startups look deceptively simple—connect buyers and sellers, take a transaction fee, and scale. Yet beneath the surface lies one of the most intricate business models in venture capital. Each marketplace comprises three intertwined systems: supply acquisition, demand generation, and transaction trust. Diligencing such a company requires investors to look beyond vanity metrics and into the structural mechanics that sustain the network. Unlike SaaS or product companies, a marketplace’s moat emerges not from technology alone but from network density, unit economics, and behavioral liquidity. Accurate diligence measures how these forces interact over time—not just whether the platform is growing, but whether it is compounding. 1. Market Definition and Network Dynamics Total Addressable Market (TAM) and Fragmentation Start with clarity on the target market’s size and fragmentation. The best marketplaces often enter highly fragmented, inefficient markets where incumbents lack digital coordination, such as real estate agents, local services, or niche B2B verticals. A large TAM alone isn’t enough; investors should assess whether participants are ready for platformization. Markets with strong offline incumbents or regulatory friction may resist the shift. Ideal markets have: Many small, independent providers have poor discovery tools. High-frequency transactions that encourage repeat use. A clear “pain point” in finding, vetting, or paying counterparties. Two-Sided Liquidity: Solving the Cold Start Problem The cold-start problem — how to attract both sides of the market simultaneously — is the defining risk for early marketplace ventures. During diligence, look for tactical liquidity strategies: Single-vertical focus: Does the company start narrow to seed density before expanding? Demand priming: Are they subsidizing one side (often the supply side) until cross-traffic builds? Community seeding: Is there an existing user base or offline network that can be digitized quickly? Early liquidity in even a small segment signals the flywheel potential that investors prize. 2. Business Model and Unit Economics Revenue Model Fit The most common monetization models include take rates (transaction fees), subscription tiers, and lead-generation fees. Each implies different risk structures. Transaction fees require trust, and an integrated payment is high-value but high-friction. Subscription models indicate recurring revenue but can mask low transaction activity. Lead models work early but limit scalability once competition rises. Investors should ask: Is the monetization aligned with the core user value? A mismatch between value creation and value capture, like charging suppliers before buyers exist, can choke early growth. Economics per Transaction Healthy marketplaces exhibit a positive contribution margin once acquisition costs normalize. During diligence, evaluate: Take rate vs. CAC: Does the average customer transaction justify the acquisition cost? Repeat usage: Is retention improving as users deepen engagement? Cohort profitability: Do earlier cohorts improve over time (a sign of compounding trust)? An investor-grade model includes LTV/CAC ratios above 3x, declining CAC, and evidence that organic or referral traffic is growing faster than paid channels. 3. Supply and Demand Validation Supply-Side Diligence Strong supply is the backbone of marketplace liquidity. Look for evidence of supply stickiness: Contracts, integrations, or switching costs that prevent churn. Platform tools that embed suppliers’ inventory management, CRM, and analytics. Precise segmentation of high-value vs. low-value suppliers. Investors should scrutinize how supply quality is maintained at scale. The best marketplaces curate, not just aggregate through reputation systems, ratings, or algorithmic filtering. Demand-Side Diligence Demand validation is equally critical. Look for signals of habitual usage: Percentage of users completing transactions vs. browsing. Repeat rate within 30–90 days. Conversion from search to transaction. If acquisition is primarily through paid channels, ask whether organic channels (SEO, referrals, word of mouth) are growing. A healthy marketplace eventually “earns” its traffic through brand trust and liquidity, not just ad spend. 4. Trust, Safety, and Transaction Infrastructure Trust is the invisible currency of marketplaces. Investors often underestimate the importance of dispute resolution, escrow systems, and user verification. Diligence questions to ask: How does the platform mitigate fraud or low-quality interactions? Is there buyer and seller verification? How quickly are disputes resolved? What share of GMV occurs on-platform versus off-platform? A marketplace with a strong safety reputation accelerates network effects. Each satisfied user adds both volume and confidence to future participants. 5. Technology, Data, and Defensibility Technology as an Enabler, Not the Moat While marketplaces are technology-enabled, their defensibility lies more in data loops than in code. Assess: Proprietary matching algorithms or dynamic pricing systems. Unique datasets built from repeated transactions. Predictive analytics is improving the balance between supply and demand. Technology amplifies the moat once scale is achieved, but rarely substitutes for it. Diligence should confirm that technology shortens the distance between intent and transaction. Network Effects and Switching Costs Ask: Do more users make the platform better for all participants? Are switching costs increasing (data lock-in, reputation scores, embedded tools)? Is there evidence of local network effects, city-by-city or niche-by-niche density? True network effects are measurable: declining CAC, improving retention, and rising transaction frequency as density grows. 6. Regulatory and Operational Risks Marketplaces often enter semi-regulated sectors (transportation, healthcare, finance). Investigate compliance exposure early: Licensing or labor classification risks (e.g., gig economy). Data privacy or payment compliance (PCI, GDPR). Local versus national jurisdiction variance. Operational diligence should review internal controls—how the company handles disputes, refunds, and payment reconciliation. Hidden liabilities here can erode margins later. 7. Team, Culture, and Execution Capability In marketplaces, execution discipline matters as much as vision. Founders must balance product growth with operational rigor. Red flags include: Overemphasis on growth without tracking unit economics. Weak analytical culture or reliance on anecdotal success stories. Lack of expertise in supply-chain or logistics for physical marketplaces. Green flags include: Founders who deeply understand both sides of the market. Clear frameworks for scaling liquidity (e.g., city rollout models). Experienced data and operations leadership. Diligence should include references and operator interviews with those who have scaled networks before, as they are rare and invaluable. 8. Investor Fit and Exit Pathways Investors must map the marketplace’s growth to their own fund model. Marketplaces can deliver large exits but often require long gestation periods before compounding effects take hold. Key investor diligence checkpoints: Time to liquidity: Are transaction volumes doubling

    Site Map

    Scroll to Top